Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v6-EN
Language French English
Date Updated 2021-01-20 2021-01-20
Drug Identification Number 02431378 02431378
Brand name PHENYTOIN SODIUM INJECTION, USP PHENYTOIN SODIUM INJECTION, USP
Common or Proper name PHENYTOIN SODIUM INJECTION, USP PHENYTOIN SODIUM INJECTION, USP
Company Name STERIMAX INC STERIMAX INC
Ingredients PHENYTOIN SODIUM PHENYTOIN SODIUM
Strength(s) 50MG 50MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 25 VIALS 5 ML 25 VIALS 5 ML
ATC code N03AB N03AB
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-12-17 2020-12-17
Estimated end date 2021-01-18 2021-01-18
Actual end date 2021-01-18 2021-01-18
Shortage status Resolved Resolved
Company comments
Health Canada comments